|
1
|
Friedman SL: Cytokines and fibrogenesis.
Semin Liver Dis. 19:129–140. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rockey DC: Current and future
anti-fibrotic therapies for chronic liver disease. Clin Liver Dis.
12:939–962. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson K, Maltby J, Fallowfield J,
McAulay M, Millward-Sadler H and Sheron N: Interleukin-10
expression and function in experimental murine liver inflammation
and fibrosis. Hepatology. 28:1597–1606. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Louis H, Van Laethem JL, Wu W, et al:
Interleukin-10 controls neutrophilic infiltration, hepatocyte
proliferation, and liver fibrosis induced by carbon tetrachloride
in mice. Hepatology. 28:1607–1615. 1998. View Article : Google Scholar
|
|
5
|
Nelson DR, Lauwers GY, Lau JY and Davis
GL: Interleukin-10 treatment reduces fibrosis in patients with
chronic hepatitis C: a pilot trail of interferon nonresponders.
Gastroenterology. 118:655–660. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang XZ, Zhang LJ, Li D, Huang YH, Chen ZX
and Li B: Effects of transmitters and interleukin-10 on rat hepatic
fibrosis induced by CCl4. World J Gastroenterol.
9:539–543. 2003.PubMed/NCBI
|
|
7
|
Rachmawati H, Reker-Smit C, Lub-de Hooge
MN, van Loenen-Weemaes A, Poelstra K and Beljaars L: Chemical
modification of interleukin-10 with mannose 6-phosphate groups
yields a liver-selective cytokine. Drug Metab Dispos. 35:814–821.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hung KS, Lee TH, Chou WY, et al:
Interleukin-10 gene therapy reverses thioacetamide-induced liver
fibrosis in mice. Biochem Biophys Res Commun. 336:324–331. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YX, Huang YH, Chen ZX, Zheng WD and
Wang XZ: Construction of eukaryotic expression plasmid containing
rat interleukin-10 gene and its expression in BRL cells in
vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 24:332–334.
2008.(In Chinese).
|
|
10
|
Ramm GA: Isolation and culture of rat
hepatic stellate cells. J Gastroenterol Hepatol. 13:846–851. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huhn RD, Radwanski E, O’Connell SM, et al:
Pharmacokinetics and immunomodulatory properties of intravenously
administered recombinant human interleukin-10 in healthy
volunteers. Blood. 87:699–705. 1996.PubMed/NCBI
|
|
12
|
Rachmawati H, Beljaars L, Reker-Smit C, et
al: Pharmacokinetic and biodistribution profile of recombinant
human interleukin-10 following intravenous administration in rats
with extensive liver fibrosis. Pharm Res. 21:2072–2078. 2004.
View Article : Google Scholar
|
|
13
|
Mathurin P, Xiong S, Kharbanda KK, et al:
IL-10 receptor and coreceptor expression in quiescent and activated
hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol.
282:G981–G990. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Safadi R, Ohta M, Alvarez CE, et al:
Immune stimulation of hepatic fibrogenesis by CD8 cells and
attenuation by transgenic interleukin-10 from hepatocytes.
Gastroenterology. 127:997–1000. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Louis H, Le Moine O, Peny MO, et al:
Production and role of interleukin-10 in concanavalin A-induced
hepatitis in mice. Hepatology. 25:1382–1389. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Stefano G, Derenzini M, Kratz F, Lanza
M and Fiume L: Liver-targeted doxorubicin: effects on rat
regenerating hepatocytes. Liver Int. 24:246–252. 2004.PubMed/NCBI
|
|
17
|
Wang S, Cheng L, Yu F, Pan W and Zhang J:
Delivery of different length poly(L-lysine)-conjugated ODN to HepG2
cells using N-stearyl lactobionamide-modified liposomes and their
enhanced cellular biological effects. Int J Pharm. 311:82–88. 2006.
View Article : Google Scholar
|
|
18
|
Lan L, Chen Y, Sun C, Sun Q, Hu J and Li
D: Transplantation of bone marrow-derived hepatocyte stem cells
transduced with adenovirus-mediated IL-10 gene reverses liver
fibrosis in rats. Transpl Int. 21:581–592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tashiro H, Shinozaki K, Yahata H, et al:
Prolongation of liver allograft survival after interleukin-10 gene
transduction 24–48 hours before donation. Transplantation.
70:336–339. 2000.
|
|
20
|
Gressner AM, Lotfi S, Gressner G and Lahme
B: Identification and partial characterization of a
hepatocyte-derived factor promoting proliferation of cultured
fat-storing cells (parasinusoidal lipocytes). Hepatology.
16:1250–1266. 1992. View Article : Google Scholar
|
|
21
|
Faouzi S, Lepreux S, Bedin C, et al:
Activation of cultured rat hepatic stellate cells by tumoral
hepatocytes. Lab Invest. 79:485–493. 1999.PubMed/NCBI
|
|
22
|
Gressner AM, Lotfi S, Gressner G, Haltner
E and Kropf J: Synergism between hepatocytes and Kupffer cells in
the activation of fat storing cells (perisinusoidal lipocytes). J
Hepatol. 19:117–132. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saile B, Knittel T, Matthes N, Schott P
and Ramadori G: CD95/CD95L-mediated apoptosis of the hepatic
stellate cell. A mechanism terminating uncontrolled hepatic
stellate cell proliferation during hepatic tissue repair. Am J
Pathol. 151:1265–1272. 1997.
|
|
24
|
Issa R, Williams E, Trim N, et al:
Apoptosis of hepatic stellate cells: involvement in resolution of
biliary fibrosis and regulation by soluble growth factors. Gut.
48:548–557. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang LJ, Zheng WD, Shi MN and Wang XZ:
Effects of interleukin-10 on activation and apoptosis of hepatic
stellate cells in fibrotic rat liver. World J Gastroenterol.
12:1918–1923. 2006.PubMed/NCBI
|
|
26
|
Chen YX, Wang XZ, Weng SG, Chen ZX, Huang
YH and Zhang LJ: Effects of interleukin-10 on the proliferation and
Fas/Fas ligand expression of hepatic stellate cells. Zhonghua Gan
Zang Bing Za Zhi. 11:637–640. 2003.(In Chinese).
|
